This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Illumina-Grail deal was properly analyzed, US FTC structure has no constitutional defects, agency tells appeals court

( August 4, 2023, 21:35 GMT | Official Statement) -- MLex Summary: The US Federal Trade Commission filed its brief in Illumina's appeal of the agency's decision to block the company's acquisition of Grail. "The Commission correctly applied the Clayton Act, its decision is supported by substantial evidence, and there is no constitutional defect in the Commission’s structure or its proceedings," the agency argued in the filing with the Fifth Circuit.See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login